Systemic dual delivery of a tumor-inhibiting plasmid expressing p16 and shRaf
Open Access
- 9 October 2025
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 787, 152773
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Biomedical Imaging and Bioengineering (R01-EB028534)
This publication has 31 references indexed in Scilit:
- Ionic Coating of siRNA Polyplexes with cRGD–PEG–Hyaluronic Acid To Modulate Serum Stability and In Vivo PerformanceBiochemistry, 2025
- pH modification of gel mobility shift improves polyplex selection In VivoBiochemical and Biophysical Research Communications, 2024
- Exploring the outer limits of polyplexesBiochemical and Biophysical Research Communications, 2023
- Epigenetic Silencing of p16INK4a gene in Sporadic Breast CancerIndian Journal of Surgical Oncology, 2023
- Dynamic mRNA polyplexes benefit from bioreducible cleavage sites for in vitro and in vivo transferJournal of Controlled Release, 2021
- Enhanced tumor uptake and activity of nanoplex-loaded doxorubicinBiochemical and Biophysical Research Communications, 2019
- ErbB Receptors and Cancer2017
- The neuropilin‐1 receptor mediates enhanced tumor delivery of H2K polyplexesThe Journal of Gene Medicine, 2016
- Increased tumor distribution and expression of histidine‐rich plasmid polyplexesThe Journal of Gene Medicine, 2014
- Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bondsBiomaterials, 2014